Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The hollow fiber assay for modeling quiescent cancer cells in vitro and in vivo 
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cancer Pharmacology and Computational Medicine. (Cancerfarmakologi och beräkningsmedicin)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cancer Pharmacology and Computational Medicine. (Cancerfarmakologi och beräkningsmedicin)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cancer Pharmacology and Computational Medicine. (Cancerfarmakologi och beräkningsmedicin)
(English)Manuscript (preprint) (Other academic)
Keywords [en]
Quiescence, dormancy, cancer
National Category
Cancer and Oncology
Research subject
Medical Science
Identifiers
URN: urn:nbn:se:uu:diva-483647OAI: oai:DiVA.org:uu-483647DiVA, id: diva2:1693536
Available from: 2022-09-07 Created: 2022-09-07 Last updated: 2022-09-09
In thesis
1. Quiescent cancer cells: Three-dimensional cell models for evaluation of new therapeutics
Open this publication in new window or tab >>Quiescent cancer cells: Three-dimensional cell models for evaluation of new therapeutics
2022 (English)Licentiate thesis, comprehensive summary (Other academic)
Alternative title[sv]
Vilande cancerceller : Tredimensionella cellmodeller för utvärdering av nya cancerläkemedel
Abstract [en]

Inadequate metabolic conditions in solid tumors lead to the formation of quiescent cancer cells that are suspended in a transient cell cycle arrest. When conditions change, quiescent cancer cells can re-enter the cell cycle and cause recurrence. Drug screening efforts have revealed mitochondrial oxidative phosphorylation as a unique metabolic dependency in quiescent cancer cells. The anthelmintic drug nitazoxanide is an inhibitor of oxidative phosphorylation and preferentially active against quiescent cancer cells in multicellular tumor spheroids. 

In this thesis, we employed current and developed new models of quiescent cancer cells and applied live cell imaging for improved preclinical evaluation of cancer drugs in hepatocellular and colorectal carcinoma cell lines. As part of this work, a new assay to measure mitochondrial membrane potential in three-dimensional cell models was developed, an application of the JC-1 assay, and we demonstrated that the preferential activity against quiescent cancer cells of nitazoxanide is shared by two kinase inhibitors: sorafenib and regorafenib. The sensitivity of quiescent cancer cells to nitazoxanide, sorafenib, and regorafenib correlated with the disruption of the mitochondrial membrane potential. Nitazoxanide and sorafenib, in combination, caused an additive decrease in viability, mitochondrial membrane potential, and colony regrowth capacity. 

Furthermore, we developed a quiescent hollow fiber assay and implemented an improved analysis using live cell imaging and adenosine triphosphate analysis. Hypoxia and cancer cell quiescence were enriched in hollow fiber macrocapsules over time, and the culture conditions affected nitazoxanide sensitivity. Additionally, we used basement membrane extract gel to support cell growth in hollow fiber macrocapsules and implanted macrocapsules in mice. We observed that the in vivo environment was favorable to cell growth. Through this characterization of the quiescent hollow fiber assay, we were able to outline important paths for future research. 

Place, publisher, year, edition, pages
Uppsala: Uppsala universitet, 2022. p. 58
Keywords
Cancer, cancer cell quiescence, dormancy, three-dimensional, multicellular tumor spheroids, model development, cancer pharmacology, mitochondria, OXPHOS, colorectal carcinoma, hepatocellular carcinoma
National Category
Cancer and Oncology
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-483620 (URN)
Presentation
2022-10-05, Hedstrandsalen, Akademiska sjukhuset ingång 70, Uppsala, 09:00 (English)
Supervisors
Available from: 2022-09-14 Created: 2022-09-09 Last updated: 2022-09-14Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Ek, FridaSelvin, ToveFryknäs, Mårten

Search in DiVA

By author/editor
Ek, FridaSelvin, ToveFryknäs, Mårten
By organisation
Cancer Pharmacology and Computational Medicine
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 63 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf